Loading...
skip to Main Content

🚨 The most important workshop in portal hypertension is just 2⃣ weeks away‼️

🚀 After the #EASLmono, #BavenoVII´s engines are at full throttle

Keyℹ️for #LiverTwitter:
🗓️ October 27-30
📖 Registration at https://www.baveno7.com
🆕 Young investigator "emerging countries" fee 📸

⚠️The scientific content of the #EASLmono is now available, on demand, on EASL Campus.

👉Replay the outstanding presentations and learn according to your schedule.

Watch on demand here: https://easlcampus.eu/list-search-taxonomy-sub/274

@VirginiaHdezGea @RautouE @EASLedu @aelsharkawy75

I'm very grateful for the opportunity offered by @EASLedu by providing me with a full bursary to attend this #easlmono meeting! #LiverTwitter

Save the date for Biliary Fibrosis: Pathophysiology and translational opportunities, 12–13 May 2023, in Florence (Italy)

If you have submitted an abstract, please note that all abstracts will be withdrawn from our system. Kindly resubmit your abstract for 2023.

If you have further questions on registration, you can reach out to monothematic@easloffice.eu.
Regarding the submission of abstracts, please reach out to abstracts@easloffice.eu.

About the EASL Monothematic Conference on Biliary Fibrosis

The pathophysiology of the biliary tree and its epithelium continues to attract strong interest. In fact, cholangiopathies (diseases of the biliary tree) represent an important cause of morbidity and mortality, and a relevant indication for liver transplantation in both the pediatric and adult population. All these diseases progress because of the deposition of fibrosis in the portal space, leading to the characteristic portal-portal septa and biliary cirrhosis.

The meeting will provide a state of the art review of recent advances on biliary fibrosis and cholangiopathies, with particular emphasis on pathophysiology, unmet clinical question, pathophysiology, and treatment opportunities.  In addition, the STC will define and reconcile current areas of controversy, delineate future avenues of research and highlight translational opportunities (novel therapies).

Who should attend?

Scientists and physicians from both the academic and industry sectors interested in biliary fibrosis.

Why should you attend this event?

  • The monothematic meeting will present and discuss the latest advances in biliary biology and pathophysiology of the biliary tree, with focus on biliary fibrosis, the main mechanisms of progression of cholangiopathies
  • Learn how epithelial cells, mesenchymal cells, Immune cells and endothelial cells communicate and interact and how morphogenetic signals orchestrate this complex mechanism.
  • These will also be discussed in the light of the pathophysiology congenital/hereditary pediatric cholangiopathies
  • Acquire a forward looking understanding of the of the relevant molecular targets and the pipeline of pharmacologic agents.

Topics to be covered

  • Update on the pathobiology of biliary diseases
  • Update on the mechanisms of biliary fibrosis
  • Role of morphogenetic signals and cellular cross-talk
  • Role of nuclear receptors and effects of their modulation
  • Biomarkers of disease progression in chronic biliary diseases.
  • New experimental models and novel molecular approaches to the treatment of cholangiopathies

Add this event to your calendar

Apple Google Office 365 Outlook Outlook.com Yahoo

🚨 The most important workshop in portal hypertension is just 2⃣ weeks away‼️

🚀 After the #EASLmono, #BavenoVII´s engines are at full throttle

Keyℹ️for #LiverTwitter:
🗓️ October 27-30
📖 Registration at https://www.baveno7.com
🆕 Young investigator "emerging countries" fee 📸

⚠️The scientific content of the #EASLmono is now available, on demand, on EASL Campus.

👉Replay the outstanding presentations and learn according to your schedule.

Watch on demand here: https://easlcampus.eu/list-search-taxonomy-sub/274

@VirginiaHdezGea @RautouE @EASLedu @aelsharkawy75

I'm very grateful for the opportunity offered by @EASLedu by providing me with a full bursary to attend this #easlmono meeting! #LiverTwitter

Back To Top